WOBURN, Mass.--(BUSINESS WIRE)--SRU Biosystems, a leader in label-free technology, publicly announced today the recipients of its Label-free Instrument Research Grants. The company awarded BIND® label-free detection systems to three research groups located at the University of Hamburg-Eppendorf, the University of Cambridge and Purdue University. The recipients were chosen on scientific merit including the level of innovation and the degree to which label-free could significantly advance breakthrough research. The supported research includes identifying new treatments for neurodegenerative diseases such as multiple sclerosis and Alzheimer’s, understanding the precise role of collagen-binding integrins in cell migration and defining the first molecular model of the Lowe Syndrome, a lethal developmental disease.
